Table 1. Comparison of patient demographics between euthyroid (group A) and hyperthyroid TAO (group B).
Group A | Group B | P-value | |
---|---|---|---|
Number of patients | 24 | 139 | |
Age (mean±SD) | 44.4±11.6 | 42.2±13.5 | 0.444 |
Sex (number of male (%)) | 10 (41.7) | 29 (20.9) | 0.038a |
Smoker (number (%)) | 8 (33.3) | 32 (23.0) | 0.278 |
Duration of eye symptom (median (IQR)) | 3.0 months (4.75) | 3.0 months (9.5) | 0.918 |
Duration of Graves' disease (median (IQR)) | N/A | 10 months (21.0) |
Abbreviation: TAO, thyroid-associated ophthalmopathy.
Independent t-test for comparisons of age.
Wilcoxon signed rank-sum test for comparisons of duration of ocular symptoms.
Chi-square test for comparison of sex ratio and smoker proportion.
P<0.05 was considered statistically significant.